Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CELTIC PLC Share Issue/Capital Change 2023

Apr 5, 2023

7553_sha_2023-04-05_ec5a1572-5d84-4721-907c-dbca6d9fd72b.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4959V

Celtic PLC

05 April 2023

CELTIC PLC

Issued share capital

As a result of the conversion of 4,079 Convertible Preferred Ordinary Shares of 100p each Celtic PLC's issued share capital as at 4 April 2023 was as follows:

94,544,911           Ordinary Shares of 1p each ("Ordinary Shares")                       

12,709,114           Convertible Preferred Ordinary Shares of 100p each ("CPO Shares")

15,797,224           Convertible Cumulative Preference Shares of 60p each ("CCP Shares")

678,766,262        Deferred Shares of 1p each

CCP Shares do not carry voting rights. Deferred Shares are not listed, are not transferable and carry no voting rights or substantive economic rights. 

The above figures for Ordinary Shares and CPO Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in voting rights under the FCA's Disclosure Guidance and Transparency Rules.

Application has been made for the admission of the 8,484 new Ordinary Shares of 1p each arising from these conversions ("New Ordinary Shares") to trading on AIM. It is expected that dealings in these New Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, is expected to commence on 13 April 2023.

Enquiries:

Company

Christopher Duffy, Company Secretary                  0141 551 4313

Canaccord Genuity Limited

Simon Bridges, Nominated Adviser                          0207 523 8350

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEBELFBXZLXBBV